Department of Endocrinology, Jiangjin Center Hospital, Chongqing, PR China.
Medicine (Baltimore). 2021 Apr 30;100(17):e25738. doi: 10.1097/MD.0000000000025738.
Whether hypothyroidism is related to non-alcoholic fatty liver disease (NAFLD) is controversial. Our aim was to investigate the relationship between NAFLD and hypothyroidism that may predict the NAFLD potential of these lesions and new prevention strategies in hypothyroidism patients.
Totally 51,407 hypothyroidism patients with average 28.23% NAFLD were analyzed by Revman 5.3 and Stata 15.1 softwares in the present study. The PubMed and Embase databases were systematically searched for works published through May 9, 2020.
The blow variables were associated with an increased risk of NAFLD in hypothyroidism patients as following: increased of thyroid stimulating hormone (TSH) levels (odds ratio [OR] = 1.23, 1.07-1.39, P = .0001); old age (mean difference [MD] = 3.18, 1.57-4.78, P = .0001); increased of body mass index (BMI) (MD = 3.39, 2.79-3.99, P < .000001); decreased of free thyroxine 4 (FT4) levels (MD = -0.28, -0.53 to -0.03, P = .03). In addition, FT3 (MD = 0.11, -0.09-0.3, P = .29) had no association with the risk of NAFLD in hypothyroidism patients.
Our systematic review identified results are as following: hypothyroidism was positively associated with the risk of NAFLD. The increased concentration of TSH levels maybe a risk factor that increased incidence of NAFLD. The BMI of NAFLD patients was significantly higher than that of non-NAFLD patients. Old age was significantly associated with the incidence of NAFLD. FT4 was significantly associated with the risk of NAFLD due to its negatively effect while FT3 was not significantly related to the risk of NAFLD. Taken together, the present meta-analysis provides strong evidence that hypothyroidism may play a vital role in the progression and the development of NAFLD.
甲状腺功能减退症是否与非酒精性脂肪性肝病(NAFLD)有关尚存在争议。我们旨在研究 NAFLD 与甲状腺功能减退症之间的关系,以预测这些病变的 NAFLD 潜力,并为甲状腺功能减退症患者提供新的预防策略。
本研究采用 Revman 5.3 和 Stata 15.1 软件对 51407 例甲状腺功能减退症患者进行分析,平均 NAFLD 为 28.23%。系统检索了PubMed 和 Embase 数据库中截至 2020 年 5 月 9 日发表的文献。
以下变量与甲状腺功能减退症患者发生 NAFLD 的风险增加有关:促甲状腺激素(TSH)水平升高(优势比[OR] = 1.23,1.07-1.39,P = 0.0001);年龄较大(平均差异[MD] = 3.18,1.57-4.78,P = 0.0001);体重指数(BMI)增加(MD = 3.39,2.79-3.99,P < 0.000001);游离甲状腺素 4(FT4)水平降低(MD = -0.28,-0.53 至-0.03,P = 0.03)。此外,FT3(MD = 0.11,-0.09 至-0.3,P = 0.29)与甲状腺功能减退症患者发生 NAFLD 的风险无关。
本系统评价的研究结果如下:甲状腺功能减退症与 NAFLD 的风险呈正相关。TSH 水平升高可能是增加 NAFLD 发生率的危险因素。NAFLD 患者的 BMI 明显高于非 NAFLD 患者。年龄较大与 NAFLD 的发生明显相关。FT4 水平与 NAFLD 的风险显著相关,因为它具有负效应,而 FT3 与 NAFLD 的风险无显著相关性。综上所述,本荟萃分析提供了有力的证据表明,甲状腺功能减退症可能在 NAFLD 的进展和发展中发挥重要作用。